Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Addex Therapeutics Ltd. Sponsored ADR (ADXN) had Normalized Income after Taxes of $-1.64M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-1.64M |
|
-- |
|
-- |
|
$0.67M |
|
$-0.67M |
|
$-0.96M |
|
$-1.64M |
|
$-1.64M |
|
$-1.64M |
|
$-1.64M |
|
$-1.64M |
|
|
Normalized Income after Taxes |
$-1.64M |
$-0.67M |
|
$-0.67M |
|
0.82M |
|
0.82M |
|
$-1.33 |
|
$-1.33 |
|
| Balance Sheet Financials | |
$3.56M |
|
$0.00M |
|
$6.99M |
|
$10.55M |
|
$1.18M |
|
-- |
|
$0.15M |
|
$1.32M |
|
$9.23M |
|
$9.23M |
|
$9.23M |
|
0.82M |
|
| Cash Flow Statement Financials | |
$-0.67M |
|
-- |
|
$0.11M |
|
$3.72M |
|
$3.14M |
|
$-0.57M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.67M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.75% |
|
-17.75% |
|
-15.53% |
|
-17.75% |
|
$11.25 |
|
$-0.81 |
|
$-0.81 |
|